These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8545121)

  • 21. Aspirin upregulates expression of urokinase type plasminogen activator receptor (uPAR) gene in human colon cancer cells through AP1.
    Jamaluddin MS
    Biochem Biophys Res Commun; 2006 Sep; 348(2):618-27. PubMed ID: 16893520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the v-Mos oncogene in male meiotic germ cells of transgenic mice results in metaphase arrest.
    Rosenberg MP; Aversa CR; Wallace R; Propst F
    Cell Growth Differ; 1995 Mar; 6(3):325-36. PubMed ID: 7794800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of urokinase expression by TNF-alpha requires the activation of binding sites for the AP-1 and PEA3 transcription factors.
    Lengyel E; Klostergaard J; Boyd D
    Biochim Biophys Acta; 1995 Jul; 1268(1):65-72. PubMed ID: 7626664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk.
    Bai W; Singh B; Yang Y; Arlinghaus RB
    Oncogene; 1992 Sep; 7(9):1757-63. PubMed ID: 1323818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The physical interactions between p37env-mos and tubulin structures.
    Bai W; Singh B; Yang Y; Ramagli LS; Nash M; Herzog NK; Arlinghaus RB
    Oncogene; 1992 Mar; 7(3):493-500. PubMed ID: 1532247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.
    Gum R; Lengyel E; Juarez J; Chen JH; Sato H; Seiki M; Boyd D
    J Biol Chem; 1996 May; 271(18):10672-80. PubMed ID: 8631874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of c-mos oncogene by integration of an endogenous long terminal repeat element during transfection of genomic DNA from mouse skin tumor cells.
    Wang S; Nishigori C; Miyakoshi J; Tsukada T; Shung B; Yagi T; Takebe H
    Oncogene; 1993 Apr; 8(4):1009-16. PubMed ID: 8455928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion.
    Simon C; Juarez J; Nicolson GL; Boyd D
    Cancer Res; 1996 Dec; 56(23):5369-74. PubMed ID: 8968087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of v-Mos with soluble vimentin in vitro and in transformed cells.
    Bai W; Arlinghaus RB; Singh B
    Oncogene; 1993 Aug; 8(8):2207-12. PubMed ID: 8336943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS.
    Resing KA; Mansour SJ; Hermann AS; Johnson RS; Candia JM; Fukasawa K; Vande Woude GF; Ahn NG
    Biochemistry; 1995 Feb; 34(8):2610-20. PubMed ID: 7873542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MyoD binds to Mos and inhibits the Mos/MAP kinase pathway.
    Solhonne B; Lenormand JL; Pelpel K; Leibovitch MP; Leibovitch SA
    FEBS Lett; 1999 Nov; 461(1-2):107-10. PubMed ID: 10561505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of a functional interaction between serine 3 and serine 25 Mos phosphorylation sites. A dominant inhibitory role of serine 25 phosphorylation on Mos protein kinase.
    Yang Y; Pham CD; Vuyyuru VB; Liu H; Arlinghaus RB; Singh B
    J Biol Chem; 1998 Jun; 273(26):15946-53. PubMed ID: 9632642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The histidine-221 to tyrosine substitution in v-mos abolishes its biological function and its protein kinase activity.
    Singh B; Wittenberg C; Hannink M; Reed SI; Donoghue DJ; Arlinghaus RB
    Virology; 1988 May; 164(1):114-20. PubMed ID: 2966489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of v-Mos kinase activity by protein kinase A.
    Yang Y; Herrmann CH; Arlinghaus RB; Singh B
    Mol Cell Biol; 1996 Mar; 16(3):800-9. PubMed ID: 8622681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD11c gene expression in hairy cell leukemia is dependent upon activation of the proto-oncogenes ras and junD.
    Nicolaou F; Teodoridis JM; Park H; Georgakis A; Farokhzad OC; Böttinger EP; Da Silva N; Rousselot P; Chomienne C; Ferenczi K; Arnaout MA; Shelley CS
    Blood; 2003 May; 101(10):4033-41. PubMed ID: 12576324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ras regulation of urokinase-type plasminogen activator.
    Lengyel E; Ried S; Heiss MM; Jäger C; Schmitt M; Allgayer H
    Methods Enzymol; 2001; 333():105-16. PubMed ID: 11400328
    [No Abstract]   [Full Text] [Related]  

  • 37. Purification and characterization of UEF3, a novel factor involved in the regulation of the urokinase and other AP-1 controlled promoters.
    Berthelsen J; Vandekerkhove J; Blasi F
    J Biol Chem; 1996 Feb; 271(7):3822-30. PubMed ID: 8632000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase.
    Fukasawa K; Rulong S; Resau J; Pinto da Silva P; Vande Woude GF
    Oncogene; 1995 Jan; 10(1):1-8. PubMed ID: 7824263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor promoter PMA stimulates the synthesis and secretion of mouse pro-urokinase in MSV-transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content.
    Belin D; Godeau F; Vassalli JD
    EMBO J; 1984 Aug; 3(8):1901-6. PubMed ID: 6541126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncogenes modulate cellular gene expression and repress glucocorticoid regulated gene transcription.
    Jaggi R; Friis R; Groner B
    J Steroid Biochem; 1988 May; 29(5):457-63. PubMed ID: 3379954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.